Abstract:
OBJECTIVE To explore the relationship between the expression of human papilloma virus (HPV)16 E6 and E7 protein in cervical carcinoma tissues of patients with cervical precancerous lesions and observe the pathogenesis of cervical carcinoma.
METHODS Totally 60 patients with cervical cancer and 60 patients with cervical intraepithelial neoplasia (CIN) who were treated in the hospital from Jan 2014 to Oct 2015 were enrolled in the study, then the HPV16 E6, E7 proteins in the lesion tissue species were detected by using immunohistochemistry Envision two-step method.
RESULTS The positive rate of expression of E6 of the cervical cancer group was 90.00%, significantly higher than 68.33% of the CIN group; the positive rate of expression of E7 of the cervical cancer group was 88.33%, significantly higher than 71.67% of the CIN group(
P<0.05).The positive rate of expression of E6 of the patients with squamous carcinoma was 97.62%, significantly higher than 72.22% of the patients with adenocarcinoma; the positive rate of expression of E7 of the patients with squamous carcinoma was 97.62%, significantly higher than 66.67% of the patients with adenocarcinoma; the positive rate of expression of E6 of the stage Ⅲ-Ⅳ patients was 100.00%, significantly higher than 79.31% of the stage Ⅰ-Ⅱ patients; the positive rate of expression of E7 of the stage Ⅲ-Ⅳ patients was 83.87%, significantly higher than 58.62% of the stage Ⅰ-Ⅱ patients(
P<0.05).The positive rate of expression of E6, E7 was not associated with degree of cell differentiation.The positive rate of expression of E6 of the stage Ⅲ patients was 86.96%, significantly higher than 56.76% of the stage Ⅰ-Ⅱ patients; the positive rate of E7 of the stage Ⅲ patients was 86.96%, significantly higher than 62.16% of the stage Ⅰ-Ⅱ patients(
P<0.05).
CONCLUSION The positive rates of expression of HPV16 E6 and E7 in the cervical carcinoma tissues are remarkably increased in the patients with cervical precancerous lesions and are closely associated with the pathological characteristics.The HPV16 E6 and E7 could be used as indicators for outcomes of cervical precancerous lesions and cervical cancer.